Trelegy Ellipta Inhaler – Fluticasone Furoate + Umeclidinium + Vilanterol

TRELEGY-ELLIPTA-100-62.5-25-MCG-INHALER

Composition: Fluticasone Furoate + Umeclidinium + Vilanterol

Dosage Form: Dry Powder Inhaler (DPI)

Therapy: Inhaled Corticosteroid (ICS) + Long-Acting Muscarinic Antagonist (LAMA) + Long-Acting Beta2-Agonist (LABA)

What is Trelegy Ellipta Inhaler?

Trelegy Ellipta is a single-inhaler triple therapy containing fluticasone furoate, umeclidinium and vilanterol. It is used as a maintenance treatment for appropriate patients with respiratory diseases such as COPD, according to the applicable country's approved product information.

The three ingredients provide complementary actions:

Fluticasone furoate – inhaled corticosteroid that reduces airway inflammation.

Umeclidinium – long-acting muscarinic antagonist that helps relax airway muscles.

Vilanterol – long-acting beta2-agonist that provides long-acting bronchodilation.

Trelegy Ellipta is designed for once-daily maintenance therapy. It should not be used as a rescue inhaler for sudden breathing difficulty.

Uses of Trelegy Ellipta

Trelegy Ellipta may be prescribed for:

Maintenance treatment of COPD

COPD associated with chronic bronchitis or emphysema

Asthma maintenance treatment, where approved and prescribed according to the local indication

Long-term control of airflow obstruction

Reduction of COPD exacerbation risk in appropriately selected patients

Important: Trelegy Ellipta is not intended for immediate relief of acute bronchospasm. Patients experiencing sudden breathing difficulty should follow their doctor's prescribed rescue-treatment plan.

Advantages of Trelegy Ellipta

1. Three medicines in one inhaler

Combines an ICS, LAMA and LABA in a single device.

2. Once-daily maintenance therapy

The US prescribing information specifies one inhalation once daily for the relevant strengths.

3. Convenient single-inhaler approach

Combining three maintenance therapies can simplify an inhaler regimen for appropriately selected patients.

4. Comprehensive airway management

The three active ingredients work through different mechanisms to address airway inflammation and bronchoconstriction.

5. Established respiratory medicine

Trelegy Ellipta has regulatory approval in major markets for specified respiratory indications; exact indications, strengths and dispensing requirements vary by country.

Disadvantages, Risks & Precautions

Trelegy Ellipta is a prescription medicine and is not suitable for everyone.

Possible adverse effects and precautions can include:

Oral thrush/candidiasis

Respiratory infections

Headache

Cough or throat irritation

Possible cardiovascular effects such as increased heart rate

Possible urinary-retention problems

Hypersensitivity reactions

Increased pneumonia risk in some COPD patients

Drug interactions

Patients should use Trelegy only according to their healthcare professional's instructions. It should not be combined with another LABA-containing medicine unless specifically directed by a healthcare professional.

Important Safety Information

Trelegy Ellipta is NOT a rescue inhaler.

Do not use it for sudden acute breathing problems. Seek urgent medical attention for severe or rapidly worsening breathing difficulty.

The prescribing information should be checked for contraindications, warnings, interactions and country-specific indications before dispensing or supplying the product.

Trelegy Ellipta Pharmaceutical Export Supply from India

Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical sourcing and international supply enquiries from India for healthcare-sector buyers, subject to applicable regulatory requirements.

We can communicate with:

Pharmaceutical distributors

Importers

Hospitals

Clinics

Pharmacies

Healthcare procurement teams

Licensed pharmaceutical wholesalers

International B2B buyers

Why Choose Cordium Pharmaceuticals?

✓ India-based pharmaceutical sourcing partner

✓ International B2B enquiry support

✓ Product and documentation coordination

✓ Export-oriented pharmaceutical supply

✓ Support for distributors and healthcare procurement teams

✓ Professional communication for international buyers

✓ Market-specific regulatory documentation can be discussed before supply

Important: Trelegy Ellipta is a prescription medicine, and the legal requirements for import, registration, prescribing and dispensing differ between countries. Buyers should verify local regulatory requirements before placing an order.

Trelegy Ellipta – Target Markets & Cities

🇸🇬 Singapore

Target cities/areas: Singapore, Jurong, Woodlands, Tampines, Bedok

SEO intent: Trelegy Ellipta Singapore | Trelegy inhaler Singapore | Trelegy Ellipta COPD inhaler Singapore

Singapore regulates therapeutic products through the Health Sciences Authority (HSA); therapeutic products must be evaluated and approved before sale, and prescription-only medicines require appropriate medical supervision.

🇲🇾 Malaysia

Target cities: Kuala Lumpur, Petaling Jaya, Shah Alam, Johor Bahru, Penang

SEO intent: Trelegy Ellipta Malaysia | Trelegy inhaler Malaysia | Trelegy Ellipta supplier Malaysia

Malaysia's National Pharmaceutical Regulatory Agency (NPRA) states that registered medicines receive a registration number beginning with MAL.

🇰🇪 Kenya

Target cities: Nairobi, Mombasa, Kisumu, Nakuru, Eldoret

SEO intent: Trelegy Ellipta Kenya | Trelegy inhaler Kenya | Trelegy Ellipta supplier Nairobi

🇺🇸 USA

Target cities: New York, Los Angeles, Chicago, Houston, Miami, Dallas, Boston, Atlanta

SEO intent: Trelegy Ellipta USA | Trelegy Ellipta inhaler USA | Trelegy COPD inhaler USA

Trelegy Ellipta has FDA-approved indications for specified COPD and asthma maintenance treatment, with strength selection depending on the indication.

🇬🇧 UK

Target cities: London, Birmingham, Manchester, Liverpool, Leeds, Glasgow, Edinburgh

SEO intent: Trelegy Ellipta UK | Trelegy inhaler UK | Trelegy Ellipta COPD UK

🇦🇪 UAE

Target cities: Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain

SEO intent: Trelegy Ellipta UAE | Trelegy inhaler Dubai | Trelegy Ellipta Abu Dhabi

🇿🇦 South Africa

Target cities: Johannesburg, Cape Town, Durban, Pretoria, Port Elizabeth

SEO intent: Trelegy Ellipta South Africa | Trelegy inhaler South Africa | Trelegy Ellipta Johannesburg